Survey on therapy of multiple sclerosis: ACT-therapeutic adherence in patients with immunomodulatory disease-modifying therapies and factors potentially influencing treatment adherence

被引:0
|
作者
Tackenberg, B. [1 ]
机构
[1] Univ Marburg, Marburg, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:266 / 267
页数:2
相关论文
共 50 条
  • [21] Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
    Menzin, Joseph
    Caon, Christina
    Nichols, Christine
    White, Leigh Ann
    Friedman, Mark
    Pill, Michael W.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S24 - S40
  • [22] Comparison of adherence and persistence in patients initiating disease-modifying therapy for multiple sclerosis
    Meletiche, D.
    Shea, T.
    Wood, F.
    Shim, B.
    Becker, E.
    Bennett, R.
    AL-Sabbagh, A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 79 - 79
  • [23] FACTORS INFLUENCING PATIENTS' WILLINGNESS TO PAY FOR DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Poudel, N.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2020, 23 : S276 - S276
  • [24] Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review
    Yoon, Ee Ling
    Cheong, Wing Loong
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 104 - 108
  • [25] A multivariate analysis of the Global Adherence Project to determine key factors associated with adherence to multiple sclerosis disease-modifying therapies
    Devonshire, V.
    Lapierre, Y.
    MacDonell, R.
    Tello, C. Ramo
    Patti, F.
    Fontoura, P.
    Suchet, L.
    Hyde, R.
    Kieseier, B. C.
    Frohman, E. M.
    MULTIPLE SCLEROSIS, 2007, 13 : S46 - S46
  • [26] Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
    Morillo Verdugo, Ramon
    Ramirez Herraiz, Esther
    Fernandez-Del Olmo, Raquel
    Roig Bonet, Montserrat
    Valdivia Garcia, Maria
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 261 - 272
  • [27] Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
    Schwarz, Carolyn
    Grover, Stephanie
    Powell, Victoria
    Noguera, Austin
    Mah, Jean
    Mar, Soe
    Mednick, Lauren
    Banwell, Brenda
    Alper, Gulay
    Graves, Jennifer
    Lotze, Timothy
    Tillema, Jan-Mendelt
    Rensel, Mary
    Gorman, Mark
    Ness, Jayne
    Waldman, Amy
    Schreiner, Teri
    Waubant, Emmanuelle
    Yeh, E. Ann
    NEUROLOGY, 2017, 88
  • [28] Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
    Schwartz, Carolyn E.
    Grover, Stephanie A.
    Powell, Victoria E.
    Noguera, Austin
    Mah, Jean K.
    Mar, Soe
    Mednick, Lauren
    Banwell, Brenda L.
    Alper, Gulay
    Rensel, Mary
    Gorman, Mark
    Waldman, Amy
    Schreiner, Teri
    Waubant, Emmanuelle
    Yeh, E. Ann
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 175 - 185
  • [29] Defining non-adherence to the injectable disease-modifying therapies in multiple sclerosis
    McKay, K. A.
    Tremlett, H.
    Patten, S. B.
    Fisk, J. D.
    Evans, C.
    Fiest, K.
    Campbell, T.
    Marrie, R. A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 339 - 340
  • [30] 'Let's stick together' Adherence to disease-modifying therapies in multiple sclerosis
    Berger, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) : 1 - 2